Identification of stage IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model.

被引：0
|
作者：
Wever, Renske
Tjien-Fooh, Felicia
Bellomo, Domenico
Quattrocchi, Enrica
Damodaran, Sindhuja Sominidi
Van Vliet, Martin
Dwarkasing, Jvalini
Meves, Alexander
Eggermont, Alexander M.
机构：
[1] SkylineDX BV, Rotterdam, Netherlands
[2] Mayo Clin, Rochester, MN USA
[3] Princess Maxima Ctr, Utrecht, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22088
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A pilot study to establish methods for using gene expression profiling maps to identify patients with melanoma risk
    Barge, J
    Bon, B
    Richard, MA
    Vitte, J
    Grob, JJ
    Verrando, P
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (06) : 1571 - 1571
  • [32] Identification of Patients At High Risk for Recurrent Venous Thromboembolism by Whole Blood Gene Expression Analysis
    Ortel, Thomas L.
    Beckman, Michele
    Hooper, W. Craig
    Lewis, Deborah A.
    Chi, Jen-Tsan A.
    Kenney, Kristy M.
    De Staercke, Christine
    Heit, John A.
    Moll, Stephan
    Philipp, Claire S.
    Manco-Johnson, Marilyn J.
    BLOOD, 2011, 118 (21) : 999 - 1000
  • [33] Identification of high-risk patients in multiple myeloma using a clonal gene signature
    Li, Jian-Rong
    Wang, Christiana
    Cheng, Chao
    CANCER RESEARCH, 2024, 84 (06)
  • [34] The identification of patients at high risk for recurrent disease after treatment for early-stage cervical cancer
    van Meir, H.
    du Burck, I. J.
    de Kam, M. L.
    Welters, M. J. P.
    van der Burg, S. H.
    Trimbos, J. B. M. Z.
    de Kroon, C. D.
    van Poelgeest, M. I. E.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (01) : 25 - 32
  • [35] The 31-Gene Expression Profile Test Outperforms AJCC in Stratifying Risk of Recurrence in Patients with Stage I Cutaneous Melanoma
    Podlipnik, Sebastian
    Martin, Brian J.
    Morgan-Linnell, Sonia K.
    Bailey, Christine N.
    Siegel, Jennifer J.
    Petkov, Valentina I.
    Puig, Susana
    CANCERS, 2024, 16 (02)
  • [36] Integration of measurable residual disease by WT1 gene expression and flow cytometry identifies pediatric patients with high risk of relapse in acute myeloid leukemia
    Ahmed, Sonia
    Elsherif, Mariam
    Yassin, Dina
    Elsharkawy, Nahla
    Mohamed, Ayman S.
    Yasser, Nouran
    Elnashar, Amr
    Hafez, Hanafy
    Kolb, Edward A.
    Elhaddad, Alaa
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [37] Dynamics of Gene Expression Profiling and Identification of High-Risk Patients for Severe COVID-19
    Rombauts, Alexander
    Bodalo Torruella, Marta
    Abelenda-Alonso, Gabriela
    Perera-Bel, Julia
    Ferrer-Salvador, Anna
    Acedo-Terrades, Ariadna
    Gabarros-Subira, Maria
    Oriol, Isabel
    Gudiol, Carlota
    Nonell, Lara
    Carratala, Jordi
    BIOMEDICINES, 2023, 11 (05)
  • [38] Chronic addiction relapse treatment: a study of the effectiveness of the high-risk identification and prediction treatment model. Part III. Conclusion and future implications of HRIPTM research
    Gerwe, CF
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2000, 19 (04) : 439 - 444
  • [39] Alum with interleukin-12 augments immunity to a melanoma peptide vaccine: Correlation with time to relapse in patients with resected high-risk disease
    Hamid, Omid
    Solomon, Jolie C.
    Scotland, Ronald
    Garcia, Marile
    Sian, Shirley
    Ye, Wei
    Groshen, Susan L.
    Weber, Jeff S.
    CLINICAL CANCER RESEARCH, 2007, 13 (01) : 215 - 222
  • [40] Gene expression/biochemical pathway signatures of prostate cancer cells of patients with high risk and moderate risk progression of disease
    Shaheduzzaman, S
    Furusato, B
    Srikantan, V
    Petrovics, G
    Nau, ME
    Valladares, M
    Zhang, W
    Sesterhenn, IA
    Vahey, M
    McLeod, DG
    Moul, JW
    Srivastava, S
    JOURNAL OF UROLOGY, 2005, 173 (04): : 62 - 62
12345